David Colleran

David Colleran is a declared insider at 2 companies (chief executive); the most frequent names are Insulet Corp and Anika Therapeutics, Inc. The record holds 42 filings, for trades running from 24 February 2016 to 14 March 2026.

Both buying and selling appear: 2 purchases worth €67k, against 6 sales worth €4.0M. Sales outweigh purchases by €3.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 14 share grants and 20 option exercises.

On 17 March 2026 came the latest disclosure, an option exercise in Anika Therapeutics, Inc. The last purchase on record was published on 12 May 2022, which is 1,623 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.